| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.05 |